CIMM at the Annual Meeting
The Annual Meeting is an extraordinary venue that fosters scientific discussions and helps build bridges across various disciplines. We encourage all CIMM members to take advantage of the opportunities presented at the Meeting to learn about the latest breakthroughs in cancer immunology, attend sessions outside your own areas of expertise, and network with other scientists and clinicians interested in cancer immunology and immunotherapy.
- Mark your calendars! The 2009 AACR Annual Meeting will convene April 18 - 22, 2009, in Denver, CO.
Inaugural Town Hall and Reception 
All interested 2008 Annual Meeting registrants were invited to attend CIMM's inaugural Town Hall and Reception, Monday, April 14, 2008. The Town Hall Meeting provided an opportunity for attendees to learn about the Working Group, meet the members of the Steering Committee, connect with old colleagues and meet new ones, and contribute ideas to help shape future CIMM initiatives.
The Town Hall was a tremendous success, attracting over 100 immunologists. Dr. Louis M. Weiner, CIMM Steering Committee Chairperson, reviewed the history of the Working Group, discussed the importance of immunology in cancer research, highlighted CIMM's achievements in 2007-2008, and revealed events being planned for 2008-2009. Fifty new members joined the group that day, which brings CIMM membership to an astounding 1,060 members.
AACR Special Conference
Tumor Immunology
Chairpersons: Louis M. Weiner, Olivera J. Finn, Dmitry I. Gabrilovich, and Alexander M. M. Eggermont
December 2 - 5, 2008
Hyatt Regency Miami, FL
In November 2006, AACR in collaboration with the AACR Cancer Immunology Task Force, hosted its first Special Conference on Tumor Immunology. The conference was a great success, attracting over 300 participants—scientists, clinicians, young investigators, and students—from across the globe.
The 2008 Special Conference on Tumor Immunology is being developed in collaboration with the Cancer Immunology Working Group. Topics will include mechanisms of immune surveillance, antibodies in cancer immunotherapy, tumor microenvironment, epigenetic regulation of tumor growth, cancer vaccines, and immune suppression in cancer. In addition to the invited talks, short talks will be presented from selected proffered abstracts.
The Conference will be a remarkable opportunity for CIMM members to hear new perspectives on innate and adaptive anti-tumor immunity, regulation of anti-tumor responses, and tumor-directed immune suppression, and to network with colleagues. We encourage you to submit an abstract and register to attend this exceptional meeting. This page will be updated as more information becomes available.